GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor
Clinical trial NCT04944888 · COMPLETED
Trial details
- NCT number
- NCT04944888
- Sponsor
- Chinese PLA General Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2023-11-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.